| > It is mind-boggling how you can market a product and sell it to a patient population knowing absolutely nothing about how it will affect them Seems the problem is that the product got classified essentially as “just a new baker baking bread”. And in that case you wouldn’t do clinical trials to see how people react to eating your exact loves of bread. Then people realized that his exact brand of bread could be given to infants, and still you wouldn’t do a clinical trial because it’s just bread. Then it seems that the production process might have been flawed in a way that doesn’t quite harm adults, but is dangerous to infants and here we are. So what really was the major flaw? Should we start doing clinical trials on all foodstuff given to infants? It likely wouldn’t have shown anything if the root cause is manufacturing process problems, because those problems would not have been present in the batches used for the clinical trial anyway. But we would end up having to test every single brand and procedure of mashed carrots to see if it caused problems in infants. That seems to be the pitch because it fits the trope of “big bad company never thought of the potential consequences of their money making scheme!” But really this might just be a straight forward case of manufacturing practices not being held to the needed standards, because a plant got thrown around between a couple of companies and the people on the ground didn’t know any better. Also, you have to now wonder if Heinz ketchup produced with the same process given to infants might cause NEC. I’m sure that even if there where such cases no-one would have been able to connect the dots. |